Background. Invasive meningococcal disease (IMD) is recognized as septicemia and/or meningitis. However, early symptoms may vary and are frequently nonspecific. Early abdominal presentations have been increasingly described. We aimed to explore a large cohort of patients with initial abdominal presentations for association with particular meningococcal strains.
Invasive meningococcal disease (IMD) is an acute and severe infection caused by Neisseria meningitidis (Nm). It is a major cause of morbidity and mortality and is responsible for 1.2 million cases of IMD and 135 000 deaths each year worldwide [1] . Invasive isolates of Nm are usually capsulated, and they are classified into serogroups according to their capsular polysaccharides. Six serogroups (A, B, C, W, X, and Y) are responsible for virtually all IMD worldwide but with variable geographical distribution [1, 2] .
Moreover, invasive meningococcal isolates frequently belong to hyperinvasive lineages that were defined on the basis of molecular typing using multilocus sequence typing (MLST). This approach determines the sequence types (STs) using DNA sequences of 7 meningococcal loci. Close STs can be grouped into clonal complexes (CCs) [3] . More recently, the next-generation sequencing methods allowed more resolution through the analysis of whole-genome sequencing (WGS) [4] . Interestingly, meningococcal hyperinvasive isolates of serogroup W (NmW) belonging to CC11 were resolved into several strains on the basis of core genome MLST: the AngloFrench-Hajj strain and the South American-United Kingdom (UK) strain [5] . The latter strain was further shown to include 2 sublineages corresponding to the recent expansion of this strain in Europe: the original UK strain and the UK 2013 strain [5, 6] . These strains and sublineages have been co-circulating in France [7] .
IMD is usually notified as septicemia and/or meningitis, but other clinical forms are also observed such as septic arthritis, pericarditis, and invasive pneumonia [8] . However, the early symptoms at the onset of the disease may vary in frequency and time of appearance. Thompson et al [9] related the frequency and time of onset of the clinical features of IMD in children and adolescents before admission to hospital. Nonspecific symptoms and signs were reported to appear early, such as leg pain, which was reported in 20%-50% of patients with a median time of onset of 7 hours before admission. Diarrhea was also reported during the first 24 hours (median time of onset, 9 hours before admission) but to a lesser extent (6.6%). Abdominal presentations were also rarely reported in a previous French study and accounted for 1% of all IMD cases between 1999 and 2002 [10] . In 2012, in Chile and among IMD cases due to isolates of serogroup W, diarrhea was the only symptom that was significantly (P = .03) overrepresented among the fatal cases compared with the survivors (56% vs 27%) [11] . More recently, Campbell et al reported that 7 of 15 IMD cases (of whom 5 died) presented predominantly with a history of acute gastrointestinal symptoms in the 24 hours before attending hospital. These cases were all provoked by the currently expanding hypervirulent capsular serogroup W strain (the South American-UK strain and its sublineages) [12] . The link of these NmW isolates with abdominal presentations of IMD remains to be evaluated in large cohorts of patients. We therefore aimed in this work to review the database of the French National Reference Centre for Meningococci (NRCM) to describe a large cohort of patients with abdominal presentation of IMD in terms of clinical, biological, and bacterial parameters. We also aimed to analyze the association of different genomic types of meningococci with abdominal presentations of IMD.
METHODS

Ethics Statement
Samples and clinical data were received at the NRCM for routine typing and epidemiological surveillance, which are institutional missions of the NRCM. Clinical information format was provided by the NRCM. Procedure of collecting samples and informations was submitted and approved by the Commission Nationale de l'Informatique et des Libertés (number 1475242/2011). The patients were informed on the secondary use of samples/data and gave their consent for this use.
Isolates and Database
This is a retrospective study using the database of the NRCM at the Institut Pasteur, Paris, France between 1991 and 2016. Isolates and samples corresponded to biologically confirmed cases of IMD, defined as a positive culture for Nm and/or positive testing via polymerase chain reaction (PCR; used since 1998) in sterile sites. IMD cases were screened using the following keywords for the clinical presentations: "abdominal pain, " "diarrhea, " "vomiting, " "peritonitis, " "appendicitis, " "appendicular syndrome, " or "gastroenteritis. " Cases were also screened for the site of sampling of peritoneal fluid.
Inclusion and Exclusion Criteria
The cases included in the present study showed the following inclusion criteria: confirmed diagnosis of IMD and at least 1 abdominal symptom within the 24 hours before IMD diagnosis, that is, (i) abdominal pain only, (ii) gastroenteritis with diarrhea and vomiting, (iii) or diarrhea only. Cases with associated comorbidities that may explain abdominal symptoms were excluded. Vomiting in the context of the meningeal syndrome without any other abdominal symptoms was not retained.
Clinical and Biological Data
Available epidemiological data (age, sex), clinical and biological data (C-reactive protein in blood), were collected from NRCM database or from medical reports of hospitalization obtained after contact (phone, mail) of the different hospitals.
Bacterial Whole-Genome Sequencing
PCR-confirmed cases were typed by MLST analysis and all cultured isolates were typed by WGS. Typing data were expressed as a genetic formula (g:P1.PorA-VR1,PorA-VR2:FetA:CC) that define the group, the 2 variable regions (VR1 and VR2) of the outer membrane protein PorA, and the VR of the protein FetA, as well as the CC.
In this manuscript, "group G" will be used to refer to both serogroup and genogroup to characterize cultured-confirmed and PCR-confirmed cases, respectively. WGS was performed by Illumina HiSeq 2000 sequencer (Illumina, San Diego, California) and assembled as previously described [13] . Sequences are available through the PubMLST database, which runs on the Bacterial Isolate Genome Sequence Database platform [14] . WGS data were analyzed using a "gene-by-gene" approach available through the PubMLST Genome Comparator tool using Nm core genome version 1.0 that includes 1605 core loci [14] . SplitsTree4 (version 4.13.1) was used to visualize the resulting distance matrices as neighbor-net networks [15] . Further genomic analyses were performed for the period 2010-2016 to compare the NmW isolates of CC11 with abdominal presentations to all the NmW isolates belonging to the CC11 in France [16] . The identification numbers of all culture isolates are given in Supplementary Table 1 to allow retrieving of WGS sequence in FASTA formats. Loci with alleles specific to isolates of serogroup W related to the South American-UK strains were characterized according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology groupings of the KEGG database (www.kegg.jp).
Statistical Analysis
Data were analyzed using the χ 2 test, Student t test, and analysis of variance, with P < .05 considered to be statistically significant.
RESULTS
Clinical Data of IMD Patients With Abdominal Presentations
One hundred fourteen patients with abdominal presentation of IMD were initially selected between 1991 and 2016, according to inclusion criteria. Among these patients, 9 were excluded for the following reasons: (i) 3 patients had abdominal pain with constipation; (ii) 2 patients had diarrhea 24 hours after the diagnosis of IMD and after starting antibiotic treatment; (iii) 1 patient had salpingitis with no link to the IMD; (iv) 2 patients had cirrhosis; and (v) 1 patient had an abdominal trauma.
The final study population consisted of 105 patients with abdominal presentations of IMD. These cases corresponded to 92 culture-confirmed cases and 13 PCR-confirmed cases ( Figure 1 ). The clinical data and characteristics of the patients were depicted in The most frequent abdominal symptom was the abdominal pain only (n = 67 [64%]). One-quarter of the cohort had gastroenteritis (n = 26 [25%]) and diarrhea only represented 11% of the cohort (n = 12). C-reactive protein level was available for 58 cases with a mean value of 198 mg/L (95% confidence interval, 161-235). In 20% of the cohort (n = 20), the abdominal presentations at the admission led to an abdominal surgery on the basis of fever and the location of the pain in the right iliac fossa. The case fatality rate (among the 79 cases with known evolution) was 24% in these IMD cases with abdominal presentations and was significantly higher than that of all IMD (10.4%; P = .007) and remain significant (P = .01) even if all patients with missing evolutionary data survived. There was no significant difference in the fatality rate between cases with or without abdominal surgery.
Bacteriological Characteristics of IMD With Abdominal Presentations
Cases with abdominal presentation (n = 105) were compared to all cases of IMD (n = 11 979) addressed to CNRM in Paris during the period of the study. Two periods of increase of diagnosis of cases with abdominal presentation were observed (Figure 2 ). The first was in the early 2000s that paralleled an increase in total cases and a predominance of serogroup C (Figure 2 ). The second period showed a sharp increase that was observed since 2014.
The most frequent group among IMD cases with abdominal presentation was group C followed by group B (Table 2) . Group W cases ranked third, followed by group Y. However, serogroup W cases increased rapidly since 2014, concomitantly with the sharp increase of IMD cases with abdominal presentation since 2014 (Figure 2 ).
There was a significantly lower proportion of group B meningococci among cases with abdominal presentations compared to all cases of IMD. In contrast, there were significantly higher proportions of groups C and W among cases with abdominal presentations compared to all cases of IMD (Figure 3 ). Clonal complex data were available for 96 of 105 cases with abdominal presentations (91%). The CC11 was responsible for most of the cases (43 cases [45%]), with 33 cases due to NmC-CC11 and 10 
a Total number of cases for which the corresponding data were available.
cases due to NmW-CC11. We also compared the distribution of CCs for IMD cases with abdominal presentations to that for all IMD. This analysis focused on the period 2010-2016 for which the MLST data were available at the CNRM for at least 89% of all IMD cases (MLST data were available for 2891 cases of 3245 IMD total cases, with percentage of completeness ranging between 87% and 94% for the period 2010-2016). There were 27 cases (5 of group B, 7 group C, 10 group W, 4 group Y, and 1 group X) of IMD with abdominal presentations and with MLST data. Similar to the whole period of the study, the distribution of cases of groups B and W for the period 2010-2016 differed significantly between all IMD cases and cases with abdominal presentations; the proportions of group B cases were, respectively, 62% vs 29%, and that of group W were, respectively, 6% vs 29% (P = .01 and P <.00001, respectively). Moreover, the proportion of CC11 cases (n = 17 [63%]) was significantly higher than that for all IMD (n = 709 [25%]; P < .0001) (Figure 4 ). Ten of these CC11 isolates belonged to group W and 7 isolates to group C.
WGS Analysis of Isolates From IMD With Abdominal Presentations
A core genome MLST tree was performed on all the 92 cultured isolates of cases with abdominal presentation with a structure similar to that usually observed with invasive isolates from IMD ( Figure 5 ). The 92 isolates were distributed mainly in the hyperinvasive CCs, in particularly, the CC11 that included mainly isolates of groups C and W. While group C isolates were in several lineages of CC11, group W isolates were all within 1 lineage ( Supplementary Figure and Figure 6 ). The recent rapid increase of cases with abdominal presentation due to serogroup W prompted us to explore the genomic relationships of these isolates with the circulating strains in Europe (the South American-UK strain and Anglo-French-Hajj strain). We recently reported the resolution of all invasive group W isolates in France between 2010 and 2016 (n = 132 cases) [16] . We therefore analyzed the core genome MLST tree of these isolates according to the presence of abdominal presentations and identified on the tree the cases with these presentations ( Figure 6 ). All isolates of the cases with abdominal presentation were exclusively located within the 2 sublineages of the South American-UK strain (the original UK strain and the UK 2013 strain). The cases with abdominal presentation represented 7.6% (n = 10) of all IMD group W cases for this period (n = 132) but they represented 17% (n = 10) of the cases due to isolates belonging to the South American-UK strain (n = 59). No major difference was detected between isolates with abdominal presentation and other isolates derived from the South American-UK strain. However, 119 loci were identical in all group W/CC11 isolates of the 2 sublineages of the South American-UK strain but differed from the isolates of group W/CC11 belonging to the Anglo-French-Hajj strain (Supplementary Table 2 ). These genes were distributed all over the chromosome. The annotation of these specific alleles revealed characterized function for 57.1% of these loci whereas there was no characterized function for 42.9%. The annotated functions were metabolic functions (35.3%); genetic information processing (14.1%); environmental information processing (5%); cellular processes (1%); and antigenic genes (1.7%). The antigenic genes were the genes encoding factor H binding protein (fHbp) and Neisseria heparin binding antigen (NHBA), 2 proteins involved in meningococcal survival in body fluids through modulation of the interaction with components of the innate immune response. These 2 proteins are also included in the protein-based vaccines targeting group B isolates.
DISCUSSION
We reported a large cohort of patients including 105 cases with initial abdominal presentation of IMD during the 24 hours prior to diagnosis. The first report of acute abdominal syndromes of invasive meningococcal infection was published in 1917 [17] . Since then, few case reports have been described [18] . We were able to find 105 cases in 27 years in France in our study (1% of all the 11979 IMD during this period). However, this presentation may be overlooked, resulting in underestimation of these forms. Abdominal symptoms such as abdominal pain, diarrhea, and vomiting are not specific and may evoke viral infections as the major differential diagnosis. The abdominal pain alone was the most frequent (64%) early presentation among these abdominal forms. Moreover, the localization of abdominal pain during IMD is frequently around the right iliac fossa, which may be misleading, as it would invoke "acute abdomen" leading to urgent, but unwarranted, surgical intervention for an acute appendicitis [19] [20] [21] [22] [23] . The delay in the appropriate management of IMD may explain the high rates of morbidity and mortality. Abdominal pain may be overlooked in young children. This is an important limitation to our retrospective study that may impact on the variables that were analyzed. However, this point further underlines the underreporting of abdominal presentation of IMD. The missing data on survival for 26 cases is another limitation to this retrospective study. In a review of 19 cases [18] of acute abdominal pain as initial presentation of IMD, 42% of surgical procedures were reported following suspicion of acute abdomen. The high case fatality rate of 24% in our study is also worrying, particularly when comparing it to the rate of 10.4% for all cases of IMD in France [24] . The recent increase of the cases with abdominal presentation since 2014 seems to be driven by the increase of IMD cases due to CC11 isolates of groups C and W. While group C isolates belonged to several lineages of CC11, group W isolates with abdominal presentation belonged exclusively to the lineage of the South American-UK strain (Figures 4 and 5) . These observations are in line with those obtained in the United Kingdom and in Chile [11, 12] suggesting that these isolates are significantly associated with abdominal presentations of IMD.
Although hyperinvasive NmW isolates of CC11 are related, several genetic changes seem to have occurred in the isolates belonging to the sublineages of the South American-UK strain compared to the isolates belonging to the Anglo-French-Hajj strain. These events may have increased transmission, leading to the recent expansion of the former isolates. These genetic differences concerned mainly genes encoding diverse metabolic classes of function (metabolism of carbohydrate, fatty acids, amino acids, and nucleic acids). This observation is in agreement with the hypothesis linking the emergence of hyperinvasive pandemic lineages of meningococci group A in sub-Saharan Africa to shifts in genes encoding metabolic functions [25] . Linking virulence and meningococcal carbohydrate metabolism has been also suggested [26, 27] . Changes in genes encoding metabolic functions may also impact genes involved in the biosynthesis of virulence factors in the bacterial wall, such as the lipooligosaccharide and peptidoglycan, which are potent inducers of inflammatory responses in meningococci [28] . Few other changes occurred in genes encoding proteins involved in virulence (eg, fHbp and NHBA) that may impact on bacterial survival. These genetic changes may therefore also increase within-host fitness of the isolates and lead to increase virulence and the induction of strong inflammatory response. Although the pathophysiology of abdominal pain in IMD remains obscure, the induction of the inflammatory response may be involved. Several hypotheses are proposed such as mesenteric hypoperfusion or septic epiploic microinfractions during the hematogenous spread or immune complex deposition [18, 29] . Inflammation and detectable meningococci were recently reported in a duodenal biopsy during a case of meningococcemia with abdominal pain due to an isolate of group W [30] .
In conclusion, abdominal presentation of IMD seems to be increasing and to be associated with the globally expanding NmW/CC11 isolates of the South American-UK strain [5, 6] . Clinicians should be aware of this atypical presentation in the differential diagnosis of fever with abdominal pain to avoid delay of management of IMD.
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